Author： Takai Noriyuki Narahara Hisashi
Publisher： MDPI
E-ISSN： 2072-6694|2|3|1683-1688
ISSN： 2072-6694
Source： Cancers, Vol.2, Iss.3, 2010-09, pp. : 1683-1688
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Because epigenetic alterations are believed to be involved in the repression of tumor suppressor genes and promotion of tumorigenesis in choriocarcinomas, novel compounds endowed with a histone deacetylase (HDAC) inhibitory activity are an attractive therapeutic approach. HDAC inhibitors (HDACIs) were able to mediate inhibition of cell growth, cell cycle arrest, apoptosis, and the expression of genes related to the malignant phenotype in choriocarcinoma cell lines. In this review, we discuss the biologic and therapeutic effects of HDACIs in treating choriocarcinoma, with a special focus on preclinical studies.
Related content
Access to resources
Recommend
Molecular and Epigenetic Mechanisms of MLL in Human Leukemogenesis
By Ballabio Erica Milne Thomas A.
Cancers, Vol. 4, Iss. 3, 2012-09 ,pp. :